UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support

Medical oncology (Northwood, London, England), 2001-01, Vol.18 (1), p.65-78

2001

Volltextzugriff (PDF)

Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia

Leukemia, 1995-11, Vol.9 (11), p.1910-1920

1995

Volltextzugriff (PDF)

Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma : A population-based study

Blood, 2000, Vol.95 (1), p.7-11

2000

Volltextzugriff (PDF)

Impact of age on survival after intensive therapy for multiple myeloma: a population‐based study by the Nordic Myeloma Study Group

British journal of haematology, 2006-05, Vol.133 (4), p.389-396

2006

Volltextzugriff (PDF)

T‐Lymphocyte Functions in Acute Leukaemia Patients with Severe Chemotherapy‐Induced Cytopenia: Characterization of Clonogenic T‐Cell Proliferation

Scandinavian journal of immunology, 1998-01, Vol.47 (1), p.54-62

1998

Volltextzugriff (PDF)

Serum levels of thrombopoietin and stem cell factor in acute leukemia patients with chemotherapy-induced cytopenia and complicating infections

Platelets (Edinburgh), 1999, Vol.10 (1), p.17-23

Foss, B.

1999

Volltextzugriff (PDF)

Interleukin 4 responses in acute leukaemia patients with severe chemotherapy-induced leucopenia

European journal of haematology, 1997-11, Vol.59 (5), p.269-276

1997

Volltextzugriff (PDF)

Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study

The Journal of clinical investigation, 1996-11, Vol.98 (9), p.2174-2183

1996

Volltextzugriff (PDF)

Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation

Haematologica (Roma), 2006-09, Vol.91 (9), p.1228-1233

2006

Volltextzugriff (PDF)

Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia

Cancer Immunology, Immunotherapy, 2004-08, Vol.53 (8), p.740-747

2004

Volltextzugriff (PDF)

Insulin-like Growth Factor-1 (IGF-1) is a Costimulator of the Expansion of Lineage Committed Cells Derived from Peripheral Blood Mobilized CD34+ Cells in Multiple Myeloma Patients

Hematology (Luxembourg), 1999-01, Vol.4 (3), p.217-229

1999

Volltextzugriff (PDF)

Survival in 86 patients, aged 15-60, with primary acute myelogenous leukemia, treated with a common program in the Norwegian health regions I, III, IV and V in the period 1990-1995

European journal of haematology, 1997-08, Vol.59 (2), p.110-114

1997

Volltextzugriff (PDF)

Cellular immune responses in multiple myeloma patients with treatment-induced cytopenia early after high-dose chemotherapy and autologous peripheral blood stem cell transplantation

Leukemia research, 2004-05, Vol.28 (5), p.461-468

2004

Volltextzugriff (PDF)

Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial

51st Annual Meeting of the American-Society-of-Hematology,2009-12-05 - 2009-12-08, 2009, Vol.114 (22), p.530-530

2009

Volltextzugriff (PDF)

A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia

Leukemia research, 2003-04, Vol.27 (4), p.323-328

2003

Volltextzugriff (PDF)

Immune haemolytic anaemia induced by glibenclamide in selective IgA deficiency

BMJ, 1987-08, Vol.295 (6594), p.366-367

1987

Volltextzugriff (PDF)

Serum concentrations of E‐selectin, P‐selectin, ICAM‐1 and interleukin 6 in acute leukaemia patients with chemotherapy‐induced leucopenia and bacterial infections

British journal of haematology, 1995-10, Vol.91 (2), p.394-402

1995

Volltextzugriff (PDF)

Chloroquine resistant falciparum malaria in East Africa

Tidsskrift for den Norske Lægeforening, 1982-10, Vol.102 (29), p.1493

1982

Volltextzugriff (PDF)

Survival after high-dose therapy with autologous stem cell support

Tidsskrift for den Norske Lægeforening, 2004-05, Vol.124 (10), p.1374-1375

2004

Volltextzugriff (PDF)

A Randomised Placebo Controlled Study With Melphalan/Prednisone Vs Melphalan/Prednisone/Thalidomide: Quality Of Life And Toxicity

13th Congress of the European-Hematology-Association,2008-06-12 - 2008-06-15, 2008, Vol.93, p.0209

2008

Volltextzugriff (PDF)

In vitro effect of r-verapamil on acute myelogenous leukemia blast cells : studies of cytokine secretion and cytokine-dependent blast proliferation

Cancer chemotherapy and pharmacology, 1995-01, Vol.37 (1-2), p.70-78

1995

Volltextzugriff (PDF)

Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts : studies of allostimulated interferon-γ secretion

Cancer Immunology, Immunotherapy, 1996-12, Vol.43 (5), p.275-282

1996

Volltextzugriff (PDF)

Lung cancer. Symptoms, signs and diagnostic criteria

Scandinavian journal of respiratory diseases, 1979-08, Vol.60 (4), p.184

1979

Volltextzugriff (PDF)

Cytokine modulation of interleukin 1 and tumour necrosis factor-α secretion from acute myelogenous leukaemia blast cells in vitro

Leukemia research, 1995, Vol.19 (1), p.15-22

1995

Volltextzugriff (PDF)

Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group

Blood, 2000-01, Vol.95 (1), p.7

2000

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(65)

Publikationsform

Sprache

Englisch
(78)
Norwegisch
(15)
Bokmål, Norwegian; Norwegian Bokmål
(4)
Dänisch
(1)
Deutsch
(1)
Norwegian Nynorsk; Nynorsk, Norwegian
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(57)
Science & Technology
(45)
Life Sciences & Biomedicine
(40)
Male
(40)
Middle Aged
(37)
Female
(36)
Adult
(34)
Biological And Medical Sciences
(22)
Aged
(21)
Adolescent
(19)
Hematology
(19)
Medical Sciences
(19)
Space Life Sciences
(11)
General & Internal Medicine
(10)
Medicine, General & Internal
(10)
Multiple Myeloma - Therapy
(10)
Oncology
(10)
Public, Environmental & Occupational Health
(10)
Sport Sciences
(10)
Transplantation, Autologous
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support

Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia

Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma : A population-based study

Impact of age on survival after intensive therapy for multiple myeloma: a population‐based study by the Nordic Myeloma Study Group

T‐Lymphocyte Functions in Acute Leukaemia Patients with Severe Chemotherapy‐Induced Cytopenia: Characterization of Clonogenic T‐Cell Proliferation

Serum levels of thrombopoietin and stem cell factor in acute leukemia patients with chemotherapy-induced cytopenia and complicating infections

Interleukin 4 responses in acute leukaemia patients with severe chemotherapy-induced leucopenia

Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study

Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation

Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemotherapy-induced leukopenia

Insulin-like Growth Factor-1 (IGF-1) is a Costimulator of the Expansion of Lineage Committed Cells Derived from Peripheral Blood Mobilized CD34+ Cells in Multiple Myeloma Patients

Survival in 86 patients, aged 15-60, with primary acute myelogenous leukemia, treated with a common program in the Norwegian health regions I, III, IV and V in the period 1990-1995

Cellular immune responses in multiple myeloma patients with treatment-induced cytopenia early after high-dose chemotherapy and autologous peripheral blood stem cell transplantation

Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial

A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia

Immune haemolytic anaemia induced by glibenclamide in selective IgA deficiency

Serum concentrations of E‐selectin, P‐selectin, ICAM‐1 and interleukin 6 in acute leukaemia patients with chemotherapy‐induced leucopenia and bacterial infections

Chloroquine resistant falciparum malaria in East Africa

Survival after high-dose therapy with autologous stem cell support

A Randomised Placebo Controlled Study With Melphalan/Prednisone Vs Melphalan/Prednisone/Thalidomide: Quality Of Life And Toxicity

In vitro effect of r-verapamil on acute myelogenous leukemia blast cells : studies of cytokine secretion and cytokine-dependent blast proliferation

Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts : studies of allostimulated interferon-γ secretion

Lung cancer. Symptoms, signs and diagnostic criteria

Cytokine modulation of interleukin 1 and tumour necrosis factor-α secretion from acute myelogenous leukaemia blast cells in vitro

Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group

Suchergebnisse filtern